CRISPR Therapeutics AG - Strategy, SWOT and Corporate Finance Report

CRISPR Therapeutics AG - Strategy, SWOT and Corporate Finance Report

Summary

CRISPR Therapeutics AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

CRISPR Therapeutics AG (CRISPR) is a gene editing company. It focuses on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform. CRISPR/Cas9 is a gene-editing technology that modifies, deletes, or corrects disease-causing abnormalities at its genetic sources. Its major development programs include ex vivo programs involving gene editing of hematopoietic cells; ex vivo programs in immuno-oncology; in vivo programs targeting the liver and additional in vivo programs targeting other organ systems including muscle and lung. It has research and development operations in Cambridge, Massachusetts, the US and business operations in London, the UK. CRISPR is headquartered in Zug, Switzerland.

Scope

• Detailed information on CRISPR Therapeutics AG required for business and competitor intelligence needs
• A study of the major internal and external factors affecting CRISPR Therapeutics AG in the form of a SWOT analysis
• An in-depth view of the business model of CRISPR Therapeutics AG including a breakdown and examination of key business segments
• Intelligence on CRISPR Therapeutics AG's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
• News about CRISPR Therapeutics AG, such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of CRISPR Therapeutics AG and the factors that influence its strategies.
• Track strategic initiatives of the company and latest corporate news and actions.
• Assess CRISPR Therapeutics AG as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on CRISPR Therapeutics AG's business structure, strategy and prospects.